当前位置： SCI文献检索 > Journal of Cancer Research and Therapeutics期刊下所有文献 > Clinical and pathological features of patients with resected synovial sarcoma: a multicenter retrospective analysis of the Anatolian Society of Medical Oncology.

Clinical and pathological features of patients with resected synovial sarcoma: a multicenter retrospective analysis of the Anatolian Society of Medical Oncology.

Abstract：

BACKGROUND:Synovial sarcoma (SS) is a rare disease and compared with other soft-tissue sarcomas has a relatively high mortality rate. The optimal management of this disease and prognostic factors associated with patient outcome remains controversial. AIMS:We aimed to evaluate the factors affecting the outcomes of SS patients in the adjuvant setting. PATIENTS AND METHODS:In this Turkish multicenter study, we assessed the data of 69 SS patients regarding prognostic factors for SS patients retrospectively. RESULTS:Our study included 69 localized SS patients (38 males and 31 females) with a median age of 34.5 years (minimum-maximum: 14-68 years). Overall survival (OS) and disease free survival (DFS) rates for 5 years were 64% and 25%, respectively. All patients under went surgical treatment; 64 patients were treated with a wide excision and 5 patients had an amputation. According to the univariate analysis, adverse prognostic factors for OS were male sex, higher mitotic activity, high Ki-67 levels, trunk localization and inadequate surgical margins. In multivariate analysis, none of these factors had independent significant association with OS. Prognostic factors for DFS; in the univariate analysis were higher mitotic activity, high Ki-67 levels and inadequate surgical margins. Only higher mitotic activity (≥10 high-power field) was significantly associated with worse DFS in the multivariate analysis (hazard ratio: 0.30, % confidence interval: 0.11-0.80, P = 0.017). CONCLUSION:Our study confirms that high mitotic activity is significantly associated with decreased DFS. The question of whether the chemotherapy provides a survival advantage in patients having adverse prognostic factors requires confirmation in randomized trials.

journal_name

J Cancer Res Ther

journal_title

Journal of cancer research and therapeutics

authors

Tarkan Y,Erkan A,Selcuk ES,Mehmet K,Tugba KF,Ozlem US,Suleyman A,Tulay A,Bilge A,Ramazan Y,Yusuf G,Mevlude I,Umut D,Ilhan O,Abdurrahman I,Alper S,Dogan U,Necati A,Berna O,Gok DA,Ugur Y,Mahmut G

doi

10.4103/0973-1482.131381

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

73-8

issue

eissn

0973-1482

issn

1998-4138

pii

JCanResTher_2014_10_1_73_131381

journal_volume

pub_type

杂志文章,多中心研究

在线工具

Clinical and pathological features of patients with resected synovial sarcoma: a multicenter retrospective analysis of the Anatolian Society of Medical Oncology.